Projects per year
Abstract
During the work of the Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II) group, we reported on vaccine uptake, safety, effectiveness, and waning in specific age groups in Scotland (e.g., 12-17 years) to enable policymakers to make decisions based on evidence generated nearly in real-time [1]. At first, these imperatives appeared methodologically straightforward. However, we soon realised that the seemingly simplest task in theory – i.e., reporting the vaccine uptake – was in fact challenging in practice. We report several caveats that need to be considered when reporting vaccine uptake for a specific age-group at a national level. We also propose a simple stepwise approach for reporting the methods of calculating vaccine uptake in a specific age-group in the context of tracking a large population.
Original language | English |
---|---|
Article number | 03006 |
Number of pages | 7 |
Journal | Journal of Global Health |
Volume | 14 |
DOIs | |
Publication status | Published - 9 Feb 2024 |
Keywords / Materials (for Non-textual outputs)
- Humans
- Influenza Vaccines
- Influenza, Human/prevention & control
Fingerprint
Dive into the research topics of 'Caveats in reporting of national vaccine uptake'. Together they form a unique fingerprint.Projects
- 2 Finished
-
-
Non-adherence to treatment: a methodological approach to compensating for its impact in chronic infections, using tuberculosis as a model disease
Stagg, H.
1/09/18 → 31/08/23
Project: Research